Distinct HIV reservoir measures correlate with defective but not intact pro-viral DNA

• E. Papasavvas,
• L. Azzoni,
• P. Tebas,
• K. Mounzer,
• J.R. Kostman,
• D. Richman,
• N. Chomont,
• B. Howell,
• L.J. Montaner

Affiliations

E. Papasavvas

Wistar Institute, Philadelphia, USA

L. Azzoni

Wistar Institute, Philadelphia, USA

P. Tebas

University of Pennsylvania, Philadelphia, USA

K. Mounzer

Jonathan Lax Immune Disorders Treatment Center, Philadelphia Field Initiating Group for HIV-1 Trials, Philadelphia, USA

J.R. Kostman

John Bell Health Center, Philadelphia Field Initiating Group for HIV-1 Trials, Philadelphia, USA

D. Richman

VA San Diego Healthcare System and the University of California, San Diego, USA

N. Chomont

University of Montreal, Montreal, Canada

B. Howell

Merck, Inc., West Point, USA

L.J. Montaner

Wistar Institute, Philadelphia, USA